Trade GRAL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
GRAIL, Inc. (GRAL) is trading at US$80.77, up 1.03% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$3.55B. Over the past 52 weeks, GRAL has traded between US$41.50 and US$118.84. On Syfe you can trade GRAL with $0 commission and add it to your watchlist.
| Previous close | US$79.95 |
|---|---|
| Market cap | US$3.55B |
| 52-week range | US$41.50 – US$118.84 |
| Volume | 2.99M |
| Exchange | US |
Add to Watchlist
Set Price Alert
GRAIL, Inc.
GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.
Year: 2024
GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel
Aug 7, 7:57 PM · MT Newswires
GRAIL, Inc. (GRAL) stock is trading at US$80.77, +1.03% from the previous close of US$79.95.
The market cap for GRAIL, Inc. (GRAL) stock is approximately US$3.55B.
The 52-week high for GRAIL, Inc. (GRAL) stock is US$118.84.
The 52-week low for GRAIL, Inc. (GRAL) stock is US$41.50.
GRAIL, Inc. (GRAL) does not currently pay a dividend.
Stay on top of GRAL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
